Atreon Orthopedic receives FDA approval for Rotium Bioresorbable Wick!

Rotium_FDA-01.jpg

Today, Atreon Orthopedics announced that the U.S. Food and Drug Administration (FDA) has cleared its proprietary product, the Rotium Bioresorbable Wick, which is intended to be used in conjunction with suture anchors for the reattachment of tendon to bone in rotator cuff repairs

Rotium Bioresorbable Wick is a a non-woven, microfiber matrix comprising biodegradable polymer fibers that mimic the extracellular matrix structure. Rotiumâ„¢ supports cellular infiltration and migration, and facilitates functional tissue regeneration.